These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2378 related items for PubMed ID: 17531446

  • 1. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 2. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS, Streit JM, Fritsche TR, Jones RN.
    Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289
    [Abstract] [Full Text] [Related]

  • 4. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS, Watters AA, Fritsche TR, Jones RN.
    BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104
    [Abstract] [Full Text] [Related]

  • 5. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    Sader HS, Jones RN, Rossi KL, Rybak MJ.
    J Antimicrob Chemother; 2009 Nov 18; 64(5):1024-8. PubMed ID: 19744978
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
    Sader HS, Becker HK, Moet GJ, Jones RN.
    Diagn Microbiol Infect Dis; 2010 Mar 18; 66(3):329-31. PubMed ID: 20159377
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR.
    J Antimicrob Chemother; 2009 Dec 18; 64(6):1226-9. PubMed ID: 19833635
    [Abstract] [Full Text] [Related]

  • 8. [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].
    Loza E, Morosini MI, Pascual A, Tubau F, Alcalá J, Liñares J, Hernández-Bello JR, Baquero F, Perea E, Martín R, Jones RN, Cantón R, SENTRY Surveillance Program, Spain (2002-2006).
    Enferm Infecc Microbiol Clin; 2008 Oct 18; 26(8):489-94. PubMed ID: 19094861
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2009 Oct 18; 65(2):158-62. PubMed ID: 19748426
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.
    Malli E, Spiliopoulou I, Kolonitsiou F, Klapsa D, Giannitsioti E, Pantelidi K, Pratti A, Panopoulou M, Grapsa S, Alepopoulou E, Neonakis I, Frantzidou F, Alexiou-Daniel S, Bakola D, Koutsia-Carouzou C, Malamou-Lada H, Zerva L, Vlahaki E, Kartali-Ktenidou S, Anastassiou ED, Petinaki E.
    Int J Antimicrob Agents; 2008 Dec 18; 32(6):525-8. PubMed ID: 18774268
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).
    Pfaller MA, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2007 Apr 18; 57(4):459-65. PubMed ID: 17240105
    [Abstract] [Full Text] [Related]

  • 12. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F, Aguilar L, González N, Giménez MJ, Torrico M, Alou L, Sevillano D, Vallejo P, Prieto J.
    J Antimicrob Chemother; 2007 Jun 18; 59(6):1185-9. PubMed ID: 17412725
    [Abstract] [Full Text] [Related]

  • 13. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT, Li Y, Wang J, China Bacterial Resistance Surveillance Study Group.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):365-74. PubMed ID: 12820911
    [Abstract] [Full Text] [Related]

  • 14. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
    Sader HS, Fritsche TR, Jones RN.
    Antimicrob Agents Chemother; 2006 Jul 10; 50(7):2330-6. PubMed ID: 16801409
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J, Kresken M, Menke A, Orland A, Weiher H, Morrissey I.
    Int J Antimicrob Agents; 2007 Mar 10; 29(3):322-5. PubMed ID: 17204403
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
    Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Dec 10; 53(4):329-32. PubMed ID: 16263233
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 119.